- Home
- INVE vs RGC Comparison
INVE vs RGC Comparison
Compare INVE & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVE
- RGC
- Stock Information
- Founded
- INVE 1990
- RGC 2014
- Country
- INVE United States
- RGC Hong Kong
- Employees
- INVE N/A
- RGC N/A
- Industry
- INVE Computer peripheral equipment
- RGC Medicinal Chemicals and Botanical Products
- Sector
- INVE Technology
- RGC Health Care
- Exchange
- INVE Nasdaq
- RGC Nasdaq
- Market Cap
- INVE 93.6M
- RGC 105.3M
- IPO Year
- INVE 1997
- RGC 2021
- Fundamental
- Price
- INVE $3.89
- RGC $4.75
- Analyst Decision
- INVE Strong Buy
- RGC
- Analyst Count
- INVE 2
- RGC 0
- Target Price
- INVE $7.25
- RGC N/A
- AVG Volume (30 Days)
- INVE 103.4K
- RGC 51.3K
- Earning Date
- INVE 11-07-2024
- RGC 12-20-2024
- Dividend Yield
- INVE N/A
- RGC N/A
- EPS Growth
- INVE N/A
- RGC N/A
- EPS
- INVE 3.10
- RGC N/A
- Revenue
- INVE $104,217,000.00
- RGC N/A
- Revenue This Year
- INVE N/A
- RGC N/A
- Revenue Next Year
- INVE N/A
- RGC N/A
- P/E Ratio
- INVE $1.27
- RGC N/A
- Revenue Growth
- INVE 70.57
- RGC N/A
- 52 Week Low
- INVE $2.95
- RGC $3.03
- 52 Week High
- INVE $9.24
- RGC $32.44
- Technical
- Relative Strength Index (RSI)
- INVE 50.54
- RGC 42.77
- Support Level
- INVE $3.89
- RGC $5.41
- Resistance Level
- INVE $4.25
- RGC $6.10
- Average True Range (ATR)
- INVE 0.20
- RGC 0.43
- MACD
- INVE -0.02
- RGC -0.08
- Stochastic Oscillator
- INVE 28.89
- RGC 27.86
About INVE Identiv Inc.
Identiv Inc is a security technology company. It secures and manages access to physical places, things, and information. The company has two reportable segments namely the Premises segment which includes solutions to address the premises security market for government and enterprise, including access control, video surveillance, analytics, customer experience, and other applications. Its Identity segment includes products and solutions enabling secure access to information serving the logical access and cyber security market and protecting assets and objects in the IoT with RFID. Geographically, it generates maximum revenue from the Americas and also has a presence in Europe and the Middle East, and Asia-Pacific. The company derives the majority of revenue from the Identity segment.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.